That was attributed in part to the growth in specialty drugs, a group of costly medicines used to treat illnesses such as cancer, multiple sclerosis and hemophilia.Spending on these emerging medications is soaring, around 20% per year, in sharp contrast to spending on traditional drugs, which is declining, according to Express Scripts.